United States · Bill · HR
H.R. 2802 (109th)
Drug Testing Integrity Act of 2005
Introduced
8 June 2005
Last action
17 June 2005 · Referred
Status
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
Sponsors
Rep. Engel, Eliot L. [D-NY-16], Rep. Davis, Danny K. [D-IL-7], Del. Christensen, Donna M. [D-VI-At Large], Rep. Terry, Lee [R-NE-2], Rep. Eshoo, Anna G. [D-CA-18]
Subjects
Discovery layer
Source updated
15 August 2025
Summary
Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance. Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 June 2005
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
8 June 2005
Introduced
Introduced in House
Source: IntroReferral
8 June 2005
Introduced
Introduced in House
Source: IntroReferral
17 June 2005
Referred
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 8 June 2005 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 8 June 2005
Introduced in House (PDF)
Introduced in House · EN · 8 June 2005
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 8 June 2005
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Engel, Eliot L. [D-NY-16] · D · Sponsor
- Rep. Davis, Danny K. [D-IL-7] · D · Cosponsor
- Del. Christensen, Donna M. [D-VI-At Large] · D · Cosponsor
- Rep. Terry, Lee [R-NE-2] · R · Cosponsor
- Rep. Eshoo, Anna G. [D-CA-18] · D · Cosponsor
- · hsif00 · Standing
Related records
- related to ← National Drug Testing Integrity Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/house-bill/2802
- Open data entity: https://api.congress.gov/v3/bill/109/hr/2802
- us · 109-hr-2802 · source updated 15 August 2025